Joseph N Graziano1. 1. Division of Cardiology, Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-0204, USA.
Abstract
BACKGROUND/ PURPOSE: Patients with congenital diaphragmatic hernia (CDH) are known to have associated cardiac anomalies. Data from the Congenital Diaphragmatic Hernia Study Group has allowed better definition of the types of heart defects (HDs) and survival for these patients. METHODS: Since 1995, 2636 patients were enrolled in the Congenital Diaphragmatic Hernia Study Group from 82 centers. Patients with hemodynamically significant HD, excluding patent ductus arteriosus (PDA); patent foramen ovale (PFO); and atrial septal defect (ASD), were selected. Cardiac anatomy and survival data for all patients were reviewed. RESULTS: Two hundred eighty (10.6%) patients had significant HDs: ventricular septal defect (VSD); (42.2%), aortic arch obstruction (15%), univentricular anatomy (13.9%), tetralogy of Fallot variants (11.1%), total anomalous pulmonary venous return (3.9%), double outlet right ventricle (RV) (3.2%), pulmonary stenosis (2.5%), transposition of the great arteries (2.5%), and various other defects in 5.7%. Survival for the entire group was 67.1%; survival for patients without HD was 70.2% and for patients with HD was 41.1% (P < .001). Patients with biventricular cardiac anatomy had a 47% survival, whereas those with univentricular anatomy had a 5% survival (P < .001). CONCLUSION: Significant HD is associated with 10.6% of CDH. Survival for patients with HD is significantly lower than for patients with normal cardiac anatomy. Patients with CDH and univentricular cardiac anatomy have a poor prognosis.
BACKGROUND/ PURPOSE:Patients with congenital diaphragmatic hernia (CDH) are known to have associated cardiac anomalies. Data from the Congenital Diaphragmatic Hernia Study Group has allowed better definition of the types of heart defects (HDs) and survival for these patients. METHODS: Since 1995, 2636 patients were enrolled in the Congenital Diaphragmatic Hernia Study Group from 82 centers. Patients with hemodynamically significant HD, excluding patent ductus arteriosus (PDA); patent foramen ovale (PFO); and atrial septal defect (ASD), were selected. Cardiac anatomy and survival data for all patients were reviewed. RESULTS: Two hundred eighty (10.6%) patients had significant HDs: ventricular septal defect (VSD); (42.2%), aortic arch obstruction (15%), univentricular anatomy (13.9%), tetralogy of Fallot variants (11.1%), total anomalous pulmonary venous return (3.9%), double outlet right ventricle (RV) (3.2%), pulmonary stenosis (2.5%), transposition of the great arteries (2.5%), and various other defects in 5.7%. Survival for the entire group was 67.1%; survival for patients without HD was 70.2% and for patients with HD was 41.1% (P < .001). Patients with biventricular cardiac anatomy had a 47% survival, whereas those with univentricular anatomy had a 5% survival (P < .001). CONCLUSION: Significant HD is associated with 10.6% of CDH. Survival for patients with HD is significantly lower than for patients with normal cardiac anatomy. Patients with CDH and univentricular cardiac anatomy have a poor prognosis.
Authors: Patrick Y Jay; Malgorzata Bielinska; Jonathan M Erlich; Susanna Mannisto; William T Pu; Markku Heikinheimo; David B Wilson Journal: Dev Biol Date: 2006-10-05 Impact factor: 3.582
Authors: Nori Matsunami; Hari Shanmugam; Lisa Baird; Jeff Stevens; Janice L Byrne; Douglas C Barnhart; Carrie Rau; Marcia L Feldkamp; Bradley A Yoder; Mark F Leppert; H Joseph Yost; Luca Brunelli Journal: Birth Defects Res Date: 2018-03-23 Impact factor: 2.344
Authors: Seema R Lalani; Stephanie M Ware; Xueqing Wang; Gladys Zapata; Qi Tian; Luis M Franco; Zhengxin Jiang; Kristine Bucasas; Daryl A Scott; Philippe M Campeau; Neil Hanchard; Luis Umaña; Ashley Cast; Ankita Patel; Sau W Cheung; Kim L McBride; Molly Bray; A Craig Chinault; Barbara A Boggs; Miao Huang; Mariah R Baker; Susan Hamilton; Jeff Towbin; John L Jefferies; Susan D Fernbach; Lorraine Potocki; John W Belmont Journal: Hum Mol Genet Date: 2013-06-16 Impact factor: 6.150
Authors: M G Peetsold; H A Heij; C M F Kneepkens; A F Nagelkerke; J Huisman; R J B J Gemke Journal: Pediatr Surg Int Date: 2008-10-08 Impact factor: 1.827
Authors: Malgorzata Bielinska; Patrick Y Jay; Jonathan M Erlich; Susanna Mannisto; Zsolt Urban; Markku Heikinheimo; David B Wilson Journal: Ann Med Date: 2007 Impact factor: 4.709